09/26/2024 | Press release | Distributed by Public on 09/26/2024 10:21
WASHINGTON - This week, U.S. Sen. Mark R. Warner (D-VA), co-chair of the Congressional Task Force on Alzheimer's Disease, applauded House passage of two bipartisan bills he introduced that would cement and build on the important progress that has been made to prevent and effectively treat Alzheimer's disease. The National Alzheimer's Project Act (NAPA) ReauthorizationAct and the Alzheimer's Accountability and Investment Act (AAIA) now head to the president's desk to be signed into law.
Nearly seven million Americans are living with Alzheimer's. Alzheimer's costs our nation an astonishing $360 billion per year, including $231 billion in costs to Medicare and Medicaid. If we continue along this trajectory, the number of people age 65 and older with Alzheimer's may grow to a projected 12.7 million and approach $1 trillion in annual costs by 2050. Family caregivers provide 18 billion hours of unpaid care for loved ones with dementia annually, valued at nearly $347 billion.
"I know from firsthand experience what a devastating illness Alzheimer's disease is, as I watched my mother battle with it for a decade before her passing," Sen. Warner said. "While we've made great strides in research, there is still so much work to be done to find effective ways to prevent and treat Alzheimer's. On behalf of the millions of American families who have been touched by Alzheimer's, I'm glad to see these two bills head to the president's desk to be signed into law."
The NAPA Reauthorization Act would:
The Alzheimer's Accountability and Investment Act would:
Along with Sen. Warner, both bills were co-authored by Sens. Susan Collins (R-ME) and Ed Markey (D-MA).
The NAPA Reauthorization Act and Alzheimer's Accountability and Investment Act are endorsed by the Alzheimer's Association and UsAgainstAlzheimer's. The NAPA Reauthorization Act is also endorsed by the National Down Syndrome Society, the National Down Syndrome Congress, and LuMind IDSC Foundation.
###